DOVA - Dova Pharmaceuticals' (DOVA) CEO David Zaccardelli on Q1 2019 Results - Earnings Call Transcript
Dova Pharmaceuticals, Inc. (DOVA)
Q1 2019 Earnings Conference Call
May 7, 2019 9:00 AM ET
Company Participants
David Zaccardelli – President and Chief Executive Officer
Mark Hahn – Chief Financial Officer
Jason Hoitt – Chief Commercial Officer
Conference Call Participants
Joe Pantginis – H.C. Wainwright
Tessa Romero – JPMorgan
Andrew Berens – SVB Leerink
Jonathan Miller – Evercore
Matt Kaplan – Ladenberg Thalmann
Presentation
Operator
Good morning, and welcome to Dova Pharmaceuticals First Quarter 2019 Financial Results and Operating Highlights Conference Call. All lines have been placed on mute to prevent any background noise. Following